Evaluation of the effect of autologous hematopoietic stem cell transplant on symptom severity using MSWS-12, AMSQ and symptomscreen in multiple sclerosis patients
Puntos clave
Symptom severity decreased in multiple sclerosis patients after transplant, indicating better management of the disease.
The evaluation utilized msws-12, amsq, and symptomscreen to assess subjective symptom changes.
Observational analysis included patients undergoing autologous hematopoietic stem cell transplant, focusing on symptom reduction.
Findings suggest that autologous stem cell therapy may improve quality of life and symptom control within this population.
Me gusta
Guardar
Compartir
Me gusta
Guardar
Compartir
Evaluation of the effect of autologous hematopoietic stem cell transplant on symptom severity using MSWS-12, AMSQ and symptomscreen in multiple sclerosis patients | Synapse
Cite This Study
Olivares-Gazca et al. (Mon,) studied this question.